Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
RADIOTHERAPY OF CUTANEOUS-B CELL LYMPHOMAS - OUR EXPERIENCE IN 31 CASES
Autore:
PICCINNO R; CACCIALANZA M; BERTI E; BALDINI L;
Indirizzi:
CLIN DERMATOL I,SERV FOTORADIOTERAPIA,VIA PACE 9 I-20122 MILAN ITALY UNIV MILAN,DEPT PHOTORADIOTHERAPY I-20122 MILAN ITALY UNIV MILAN,INST DERMATOL CLIN & PEDIAT DERMATOL 1,DERMATOL CLIN 1 I-20122 MILAN ITALY UNIV MILAN,OSPED MAGGIORE POLICLIN IRCCS,CTR BLOOD DIS I-20122 MILAN ITALY
Titolo Testata:
International journal of radiation oncology, biology, physics
fascicolo: 2, volume: 27, anno: 1993,
pagine: 385 - 389
SICI:
0360-3016(1993)27:2<385:ROCCL->2.0.ZU;2-X
Fonte:
ISI
Lingua:
ENG
Soggetto:
MALIGNANT-LYMPHOMA; RADIATION-THERAPY; DISEASE; PROGNOSIS; HEAD; NECK;
Keywords:
B-CELL LYMPHOMA; SKIN; CUTANEOUS B-CELL LYMPHOMA; RADIOTHERAPY;
Tipo documento:
Note
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
27
Recensione:
Indirizzi per estratti:
Citazione:
R. Piccinno et al., "RADIOTHERAPY OF CUTANEOUS-B CELL LYMPHOMAS - OUR EXPERIENCE IN 31 CASES", International journal of radiation oncology, biology, physics, 27(2), 1993, pp. 385-389

Abstract

Purpose: Since cutaneous B cell lymphomas belong mostly to low or intermediate histologic grade of malignancy and have low tendency to spreading, a local treatment such as radiotherapy appears to be a suitablechoice in the management of the disease. The authors have reviewed their cases to verify this statement. Methods and Materials: 31 patientsaffected by cutaneous B cell lymphomas classified as IE stage according to Ann Arbor received radiotherapy with orthovoltage techniques with total doses per field ranging from 10 to 40 Gy (median dose 30 Gy). All the patients had a minimum follow-up of 2 years. Results: All the target skin lesions underwent complete remission. In 10 patients (32.2%) the clinical remission is still lasting. In 21 cases (67.8%) a disease relapse was observed: only at skin in other sites than those previously treated in 17 (81%), at skin and lymph nodes in two cases (9.5%), at skin, bone, and lymph node in one case (4.7%), at skin and bowel in one case (4.7%). The extracutaneous involvement occurred in cases with lesions of intermediate grade malignancy. After a new course of radiotherapy for skin lesions only, and chemotherapy, surgery or megavoltage radiotherapy for the other involvements, on the whole 21 patients(67.8%) got a complete remission. Conclusion: On the basis of their results and of a review of the literature, the authors propose radiotherapy as the choice treatment of primary cutaneous B cell lymphomas.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/12/20 alle ore 10:33:11